{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013937","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2025-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.240259+00:00","generated_at":"2026-05-19T18:15:37.841564+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Bone Biologics announces 1-for-6 reverse stock split effective June 10, 2025","bullets":["Reverse stock split ratio of 1-for-6, effective 12:01 a.m. ET on June 10, 2025.","Common stock to trade on Nasdaq under symbol BBLG starting June 10; warrants unchanged (BBLGW).","New CUSIP for common stock is 098070600; par value remains $0.001 per share.","Fractional shares rounded up to nearest whole share; authorized shares unchanged.","Proportionate adjustments to exercise prices and shares issuable under warrants and equity awards."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013937","json":"https://secwatch.observer/filing/0001641172-25-013937.json","markdown":"https://secwatch.observer/filing/0001641172-25-013937.md","text":"https://secwatch.observer/filing/0001641172-25-013937.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225013937/0001641172-25-013937-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225013937/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T18:15:37.841564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d9f2c00ecb05a3a994d0e79134d9ab340f4a7849","claim":"Bone Biologics Corp: Amendment to Amended and Restated Certificate of Incorporation to effect a 1-for-6 reverse stock split of common stock (effective 2025-06-10).","evidence_excerpt":"On June 5, 2025, Bone Biologics Corporation (the “Company”) filed a Certificate of Amendment to amend its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware. The Certificate of Amendment effects a reverse stock split of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a ratio of 1-for-6 shares, effective as of 12:01 a.m. Eastern Time on June 10, 2025 (the “Reverse Stock Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1419554/000164117225013937/0001641172-25-013937-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-10"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}